Insider Transactions in Q1 2025 at Alignment Healthcare, Inc. (ALHC)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
30,000
-1.23%
|
$450,000
$15.99 P/Share
|
|
Mar 13
2025
|
General Atlantic LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
37,420
+0.06%
|
-
|
|
Mar 13
2025
|
General Atlantic (Aln Hlth), L.P. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
37,420
+0.06%
|
-
|
|
Mar 13
2025
|
Mark B. Mc Clellan Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,258
+3.32%
|
-
|
|
Mar 13
2025
|
Nicholas Robbert Vorhoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,710
+10.81%
|
-
|
|
Mar 13
2025
|
David C Hodgson Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,710
+10.81%
|
-
|
|
Mar 13
2025
|
Jody L Bilney Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,484
+12.03%
|
-
|
|
Mar 13
2025
|
Joseph S Konowiecki Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,258
+1.06%
|
-
|
|
Mar 13
2025
|
Jacqueline B Kosecoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,258
+4.04%
|
-
|
|
Mar 13
2025
|
Margaret M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,258
+8.69%
|
-
|
|
Mar 13
2025
|
Yon Jorden Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,258
+11.68%
|
-
|
|
Mar 13
2025
|
Hakan Kardes Chief Experience Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,677
+5.24%
|
-
|
|
Mar 13
2025
|
Robert L. Scavo Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,868
+6.38%
|
-
|
|
Mar 13
2025
|
Robert Thomas Freeman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
93,548
+5.88%
|
-
|
|
Mar 13
2025
|
Hyong Kim Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
58,065
+9.64%
|
-
|
|
Mar 13
2025
|
Christopher J Joyce Chief Legal and Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,789
+13.39%
|
-
|
|
Mar 13
2025
|
Sebastian Burzacchi COO - Mgmt Services Org |
BUY
Grant, award, or other acquisition
|
Direct |
39,677
+13.37%
|
-
|
|
Mar 13
2025
|
Dawn Christine Maroney President |
BUY
Grant, award, or other acquisition
|
Direct |
170,968
+6.53%
|
-
|
|
Mar 13
2025
|
John E Kao Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
338,710
+6.32%
|
-
|
|
Mar 13
2025
|
Andreas P. Wagner Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,109
+12.95%
|
-
|
|
Mar 12
2025
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
5,313
-0.39%
|
$79,695
$15.58 P/Share
|
|
Mar 12
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
53,122
-0.56%
|
$796,830
$15.58 P/Share
|
|
Mar 12
2025
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,692
-0.52%
|
$220,380
$15.58 P/Share
|
|
Mar 12
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
27,243
-0.59%
|
$408,645
$15.58 P/Share
|
|
Mar 12
2025
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
4,856
-0.36%
|
$72,840
$15.58 P/Share
|
|
Mar 11
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
90,000
-2.06%
|
$1,350,000
$15.54 P/Share
|
|
Mar 07
2025
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
21,574
-2.13%
|
$323,610
$15.35 P/Share
|
|
Mar 06
2025
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
55,403
-7.6%
|
$831,045
$15.53 P/Share
|
|
Mar 06
2025
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,626
-1.48%
|
$114,390
$15.53 P/Share
|
|
Mar 06
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
278,917
-10.8%
|
$4,183,755
$15.53 P/Share
|
|
Mar 06
2025
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
10,871
-2.73%
|
$163,065
$15.53 P/Share
|
|
Mar 06
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
554,713
-10.49%
|
$8,320,695
$15.53 P/Share
|
|
Mar 06
2025
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
218,295
-13.34%
|
$3,274,425
$15.53 P/Share
|
|
Mar 06
2025
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
86,659
-11.26%
|
$1,299,885
$15.53 P/Share
|
|
Mar 05
2025
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
13,394
-2.53%
|
$200,910
$15.72 P/Share
|
|
Mar 04
2025
|
Robert L. Scavo Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
292,000
+28.6%
|
-
|
|
Mar 04
2025
|
Hyong Kim Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
58,400
+9.94%
|
-
|
|
Mar 04
2025
|
Dawn Christine Maroney President |
BUY
Grant, award, or other acquisition
|
Direct |
1,020,442
+28.32%
|
-
|
|
Mar 04
2025
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
25,000
-5.91%
|
$375,000
$15.58 P/Share
|
|
Mar 04
2025
|
Christopher J Joyce Chief Legal and Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
58,400
+12.14%
|
-
|
|
Mar 04
2025
|
John E Kao Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,543,124
+32.47%
|
-
|
|
Mar 04
2025
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
250,000
-13.26%
|
$3,750,000
$15.58 P/Share
|
|
Mar 04
2025
|
Robert Thomas Freeman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,020,442
+35.11%
|
-
|
|
Mar 04
2025
|
Hakan Kardes Chief Experience Officer |
BUY
Grant, award, or other acquisition
|
Direct |
474,208
+38.12%
|
-
|
|
Mar 03
2025
|
Dawn Christine Maroney President |
SELL
Bona fide gift
|
Direct |
13,647
-0.87%
|
-
|
|
Feb 18
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
30,000
-1.87%
|
$390,000
$13.72 P/Share
|
|
Feb 12
2025
|
Andreas P. Wagner Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
14,878
-6.9%
|
$208,292
$14.38 P/Share
|
|
Feb 11
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
90,000
-3.96%
|
$1,260,000
$14.23 P/Share
|
|
Jan 24
2025
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
14,500
-4.68%
|
$203,000
$14.98 P/Share
|
|
Jan 21
2025
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
10,500
-3.28%
|
$147,000
$14.99 P/Share
|